Edited by Ming-Ching Shen, Shu-Wha Lin, Ching-Ping Tseng and Jiaan-Der Wang.
Citation: Thrombosis Journal 2016 14(Suppl 1):37
Volume 14 Supplement 1
Publication of this supplement was funded by APSTH 2016. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.
Taipei, Taiwan6-9 October 2016
Edited by Ming-Ching Shen, Shu-Wha Lin, Ching-Ping Tseng and Jiaan-Der Wang.
Citation: Thrombosis Journal 2016 14(Suppl 1):37
Von Willebrand disease (VWD) is not uncommon in Taiwan. In type 2 or type 3 VWD hemorrhagic symptoms are severer and laboratory data relatively more distinctive. De novo mutation and somatic mosaicism of type 2 V...
Citation: Thrombosis Journal 2016 14(Suppl 1):36
Thrombosis and coagulopathy are the commonest hematological manifestations of envenomation of Russell’s viper venom (RVV). Factor X is activated by a factor X-activating enzyme from Russell’s viper venom (RVV-...
Citation: Thrombosis Journal 2016 14(Suppl 1):38
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and acquired hematopoietic stem cell disease, with florid clinical presentations. Although this disease has been characterized in the western countries, its ...
Citation: Thrombosis Journal 2016 14(Suppl 1):39
Thrombopoietin was posited to exist in 1958 and cloned in 1994, and in the ensuing two decades we have learned a great deal about the physiology and pathology of the primary regulator of thrombopoiesis. This p...
Citation: Thrombosis Journal 2016 14(Suppl 1):40
Platelets play a key role in the pathophysiological processes of hemostasis and thrombus formation. However, platelet functions beyond thrombosis and hemostasis have been increasingly identified in recent year...
Citation: Thrombosis Journal 2016 14(Suppl 1):27
Platelets are central mediators of thrombosis and hemostasis. At the site of vascular injury, platelet accumulation (i.e. adhesion and aggregation) constitutes the first wave of hemostasis. Blood coagulation, ...
Citation: Thrombosis Journal 2016 14(Suppl 1):29
Multiple functions of platelets in various physiological and pathological conditions have prompted considerable attention on understanding how platelets are generated and activated. Of the adaptor proteins tha...
Citation: Thrombosis Journal 2016 14(Suppl 1):28
Inhibitors are the most serious side effect of haemophilia treatment; they occur in 25–30 % of all patients with severe haemophilia A. Over the last 2 decades, conflicting data on the impact of clotting produc...
Citation: Thrombosis Journal 2016 14(Suppl 1):31
Retrospective and prospective studies unambiguously show that prophylactic treatment of severe hemophilia A or B should be started as primary prophylaxis at 1–2 years’ of age and ideally before the first joint...
Citation: Thrombosis Journal 2016 14(Suppl 1):30
Prophylaxis is considered optimal care for hemophilia patients to prevent bleeding and to preserve joint function thereby improving quality of life (QoL). The evidence for prophylaxis is irrefutable and is the...
Citation: Thrombosis Journal 2016 14(Suppl 1):32
As life expectancy greatly increases in persons with hemophilia (PWH), more age-related diseases such as cancer and cardiovascular disease (CVD) emerge among this patient group. The aim of this study was to re...
Citation: Thrombosis Journal 2016 14(Suppl 1):34
Preimplantation genetic diagnosis (PGD) is a powerful tool to tackle the transmission of monogenic inherited disorders in families carrying the diseases from generation to generation. It currently remains a ch...
Citation: Thrombosis Journal 2016 14(Suppl 1):33
This review summarizes the evidence that collagen IV binding is physiologically important, and that the extravascular compartment of FIX is composed of type IV collagen. As we have previously demonstrated, 7 d...
Citation: Thrombosis Journal 2016 14(Suppl 1):35
Current treatment of hemophilia A (HemA) patients with repeated infusions of factor VIII (FVIII; abbreviated as F8 in constructs) is costly, inconvenient, and incompletely effective. In addition, approximately 25...
Citation: Thrombosis Journal 2016 14(Suppl 1):41
Hemophilia is the most well-known hereditary bleeding disorder, with an incidence of one in every 5000 to 30,000 males worldwide. The disease is treated by infusion of protein products on demand and as prophyl...
Citation: Thrombosis Journal 2016 14(Suppl 1):22
Venous thromboembolism (VTE), which constitutes pulmonary embolism and deep vein thrombosis, is a common disorder associated with significant morbidity and mortality. Landmark trials have shown that direct ora...
Citation: Thrombosis Journal 2016 14(Suppl 1):23
Venous thrombosis which mainly manifests as deep vein thrombosis of the leg or pulmonary embolism occurs in 1 per 1000 per year. It occurs due to interacting genetic, environmental and behavioral risk factors....
Citation: Thrombosis Journal 2016 14(Suppl 1):24
In recent years, genetic analyses of congenital deficiencies of three anticoagulant proteins, antithrombin, protein C (PC) and protein S (PS), in East Asian patients with venous thromboembolism (VTE) have grea...
Citation: Thrombosis Journal 2016 14(Suppl 1):25
Thrombosis is a common complication in cancer patients. Although the major inherited risk factors for thrombophilia are different between Asians and Caucasians, the main acquired risk factors that are associat...
Citation: Thrombosis Journal 2016 14(Suppl 1):26
The group of new oral anticoagulants or NOACs, now termed direct oral anticoagulants or DOACs, with their favourable results from large scale phase III clinical trials, represent a major advancement and expand...
Citation: Thrombosis Journal 2016 14(Suppl 1):17
Atherosclerosis is one of the major causes of death. Data from animal experiments suggest that atherosclerosis involves an inflammatory process of the vascular wall under hyperlipidemia. Atherothrombosis can b...
Citation: Thrombosis Journal 2016 14(Suppl 1):21
Snake venoms affect blood coagulation and platelet function in a complex manner. However, two classes of venom proteins, snaclecs and disintegrins have been shown to specifically target receptors including GPI...
Citation: Thrombosis Journal 2016 14(Suppl 1):18
Atypical hemolytic uremic syndrome (aHUS) is a rare genetic disorder caused by defective complement regulation resulting in thrombotic microangiopathy (TMA). Patients can present as children or adults. The syn...
Citation: Thrombosis Journal 2016 14(Suppl 1):19
The antiphospholipid syndrome (APS) is an autoimmune disease characterised by a procoagulant state that predisposes to recurrent thrombosis and miscarriages. Two major discoveries have advanced our understandi...
Citation: Thrombosis Journal 2016 14(Suppl 1):20
Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.
Members of APSTH are entitled to a 15% discount on the article processing charge.
Speed
51 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
102 days from submission to acceptance
45 days from acceptance to publication
Citation Impact
2.295- Impact Factor
1.235 - Source Normalized Impact per Paper (SNIP)
10.895 - SCImago Journal Rank (SJR)
Usage
270,557 Downloads
242 Altmetric mentions